Clinical trial
Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant
NCT00231712 is registered in ClinicalTrials.gov with Julius-Maximilians University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Analysis of the Patterns of Immune Reconstitution Following Conventional or High-Dose Chemotherapy With Autologous/Allogeneic Stem Cell Transplant
- Lead sponsor
- Julius-Maximilians University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 31, 2005
- Completion date
- February 28, 2009
- Enrollment
- 50
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.